Agents for the treatment of skin diseases

A pharmaceutical composition characterized by 0.1 to 50% of 2-hydroxy-5-methyllaurophenone (HMLO) as an active ingredient in formulations together with typical auxiliaries and / or excipients and 0.1 to 40% of normally occurring in the skin hydrating substances and / or moisturizer and / or penetration promoters selected from: (A) urea (B) urea and propylene glycol (C) propylene glycol, and a bile acid (D) urea, and propylene glycol and a bile acid.